Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills


!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-DICLO SR APOTEX INC Actual shortage 100MG New Report 2023-12-01 212392
APO-BROMFENAC APOTEX INC Actual shortage 0.07% New Report 2023-12-01 212389
APO-PERINDOPRIL/AMLODIPINE APOTEX INC Actual shortage 2.5MG 3.5MG New Report 2023-12-01 212386
APO-HYDROMORPHONE APOTEX INC Actual shortage 2MG New Report 2023-12-01 212383
APO-SUMATRIPTAN APOTEX INC Actual shortage 50MG New Report 2023-12-01 212380
APO-TERBINAFINE APOTEX INC Actual shortage 250MG Updated Report 2023-12-01 212377
APO-DOXYCYCLINE MR APOTEX INC Actual shortage 40MG New Report 2023-12-01 212374
APO-METHYLPHENIDATE ER APOTEX INC Actual shortage 27MG New Report 2023-12-01 212371
APO-DARIFENACIN APOTEX INC Actual shortage 15MG New Report 2023-12-01 212368
APO-DOXYLAMINE/B6 APOTEX INC Actual shortage 10MG 10MG New Report 2023-12-01 212365

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
RIVA-LEVOFLOXACIN LABORATOIRE RIVA INC. Discontinued 750MG New Report 2023-12-01 212230
RIVA-LEVOFLOXACIN LABORATOIRE RIVA INC. Discontinued 500MG New Report 2023-12-01 212227
RIVA-LEVOFLOXACIN LABORATOIRE RIVA INC. To be discontinued 250MG New Report 2023-12-01 212224
TAZORAC ALLERGAN INC Discontinued 0.05% Updated Report 2023-12-01 204564
STIEVA-A GLAXOSMITHKLINE INC Discontinued 0.025% Updated Report 2023-11-29 200920